DipCatcher by KAWUMSFRAclosedLONclosedNYCclosed
€FRA…
£LON…
$NYC…
₿BTC24/7
Next analysis …Last run 12:30 pm · 0 4–5 ★ · 28 3 ★
Market
IREN$21.64+20.0%AXON$313.00-18.2%CIFR$6.55+17.9%TEAM$153.68-16.2%HUT$52.65+14.6%COHR$192.81+13.6%RIOT$16.71+13.2%STM.DE€14.24-12.0%ABNB$189.99+11.7%SHIB$0.0000+11.5%AMD$449.04+11.0%VST$124.80+10.6%HFG.DE€2.99-10.4%MCHP$58.35-10.0%APP$391.22+9.9%NRG$88.29+9.6%SPCX$134.27+8.6%CLSK$6.16+8.5%LRCX$200.44+8.2%MARA$6.35+8.0%CRL$337.52+7.8%INTC$56.28+7.7%EMG.L297.00 p-7.6%ANET$170.80+7.3%AKAM$83.09+6.7%KLAC$138.49+6.7%BT-A.L217.00 p-6.4%Q$117.00+6.3%PWR$540.90+6.3%HAG.DE€77.44-6.2%GFS$38.62+6.2%SMCI$28.76+6.2%CHTR$118.07-6.2%PODD$146.51-6.2%DXCM$79.41-6.0%CNC$69.74-6.0%MRVL$141.20+5.7%LITE$538.59+5.7%HOT.DE€365.60+5.5%QCOM$165.41+5.5%CIEN$243.39+5.5%FIX$1,017.50+5.4%HUM$433.74+5.3%MRNA$254.19+5.3%GLXY$13.66+5.2%ECHO$94.62+5.2%MPWR$1,190.44+5.2%MU$690.00+5.1%AIXA.DE€30.41+5.1%ASML$1,424.75+5.0%NDX1.DE€42.98+5.0%VTRS$19.91+5.0%DLTR$131.14-4.9%EXPE$259.24-4.9%NEM.DE€64.75-4.8%GDDY$114.38-4.8%WYNN$83.11+4.8%BKNG$160.66-4.8%ARM$174.62+4.7%BEN$33.73+4.7%

Medtronic plc

$101.80-2.9% today

MDT · NYSE · USD · Healthcare

As of 1:45 am

Price

+32.8% since 07/05/2026
signal6-week high$106.2007/05/202610/08/202607/11/2026

6 months · High $106.20 (-4.1%) · Low $72.06

1What is happening

Medtronic plc has fallen 4% since its 6-week high on 05/11/2026. How it continues – phase and signs – you see with a free account.

Free account · 3 stocks and coins a day

from the 6-week high-4.1%

Other view · 26 analystsHorizon: 12 months20 Buy · 10 Hold · 0 Sell

2Our assessment

No dip32

How it continues – phase and signs – you see with a free account.

3Your next step

Marking places no order – it only helps you keep track.

More details · reasons, figures, alerts

How deep is the dip?

  • from the 6-week high-4.1%

    Highest daily price: $106.20 on 05/11/2026 · reference of the assessment · also the highest of the last 3 months

  • from the 52-week high-4.3%

    Highest price in 52 weeks: $106.33 (Yahoo)

What analysts expect

Most of the 26 analysts say buy. They look about 12 months ahead – DipCatcher only 14 trading days.

Buy
2067 %
Hold
1033 %
Sell
00 %

Average price target$104.62

$85.00 to $121.00 · today $101.80

$85.00Ø $104.62$121.00

What is a price target?

The price an analyst expects in about 12 months. Estimates are often far apart and change frequently.

Third-party opinion, not an assessment by DipCatcher. Source: public analyst estimates, as of 08/11/2026. Not financial advice.

Dates

The company in figures

Market value
130.2 bn $
All shares together at the current price.
P/E
25
Price divided by earnings per share, last 12 months.
Dividend yield
2.83 %
Yearly dividend relative to the price.
52-week range
$73.31 – $106.33
Lowest and highest price of the last year.
Your move on this one?Sign in to record it
Your take on this verdict?Sign in to react

Catalysts

37 h ago
News, last 10 days
no recent news
Next earnings
24/11/2026 · in 18 days
Last report
01/09/2026 +4.5% vs estimate

Key figures

Market value
130.2 bn $Large cap
P/E
25.0
Dividend yield
2.83 %
Volume today
0.4 × Øbelow usual
Beta
0.57swings less than the market
52-week range
$73.31 – $106.33price at 86 % of the range

About Medtronic plc

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps an

Headquarters:
Galway, Ireland
52-week range:
$73.31 – $106.33
Website:
medtronic.com

Trade levels

Why the engine says so

History for this stock or coin

Watch and alert

See which stocks they are

The engine is watching these dips right now. A free account shows the names and opens 3 full analyses a day.

  • 3 full analyses a dayWith entry, target, stop and the reasons behind them.
  • WatchlistFollow the stocks you care about.
Create a free account

Free, no payment details.

Signals are generated automatically from price, volume and technical indicators. They are not investment advice.← Back to search

Not investment advice. Investing carries risk up to total loss.